1. Home
  2. CAL vs VIR Comparison

CAL vs VIR Comparison

Compare CAL & VIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Caleres Inc.

CAL

Caleres Inc.

HOLD

Current Price

$12.18

Market Cap

450.1M

ML Signal

HOLD

Logo Vir Biotechnology Inc.

VIR

Vir Biotechnology Inc.

HOLD

Current Price

$6.02

Market Cap

825.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CAL
VIR
Founded
1878
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Shoe Manufacturing
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
450.1M
825.0M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
CAL
VIR
Price
$12.18
$6.02
Analyst Decision
Hold
Strong Buy
Analyst Count
1
11
Target Price
$14.00
$25.73
AVG Volume (30 Days)
1.1M
1.9M
Earning Date
12-09-2025
11-05-2025
Dividend Yield
2.15%
N/A
EPS Growth
N/A
N/A
EPS
0.62
N/A
Revenue
$2,702,018,000.00
$16,860,000.00
Revenue This Year
$2.22
N/A
Revenue Next Year
$3.67
$46.25
P/E Ratio
$21.05
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.54
$4.16
52 Week High
$23.82
$14.45

Technical Indicators

Market Signals
Indicator
CAL
VIR
Relative Strength Index (RSI) 43.97 48.15
Support Level $12.62 $5.76
Resistance Level $13.42 $6.12
Average True Range (ATR) 0.57 0.32
MACD -0.14 -0.06
Stochastic Oscillator 5.99 22.18

Price Performance

Historical Comparison
CAL
VIR

About CAL Caleres Inc.

Caleres Inc is a footwear company that operates retail shoe stores and e-commerce websites, and designs, develops, sources, manufactures, and distributes footwear for people of all ages. The Company's business operations are organized into two reportable segments - famous Footwear and Brand Portfolio. The famous Footwear segment is comprised of its famous Footwear retail stores, famousfootwear.com, and famousfootwear.ca. The famous Footwear segment operated around 846 stores at the end of 2024. The Brand Portfolio segment offers retailers and consumers a cultivated portfolio of known brands. Geographically, the company generates the majority of its revenue from Domestic operations.

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.

Share on Social Networks: